FdaApplication

ANDA 212041

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSCIEGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2020-09-15

Products (3)

ProductActive ingredientStrengthDosage form
LISINOPRILLISINOPRIL5MGTABLET;ORAL
LISINOPRILLISINOPRIL10MGTABLET;ORAL
LISINOPRILLISINOPRIL2.5MGTABLET;ORAL

3 products